Edgewise Therapeutics Inc... (EWTX)
28.98
1.46 (5.31%)
At close: Jan 15, 2025, 12:01 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -100.16M | -67.64M | -42.81M | -17.12M | -9.71M |
| Depreciation & Amortization | 1.73M | 538.00K | 272.00K | 185.00K | 123.00K |
| Stock-Based Compensation | 17.56M | 10.92M | 4.40M | 354.00K | 77.00K |
| Other Working Capital | -1.47M | 4.04M | 1.98M | 1.43M | 59.00K |
| Other Non-Cash Items | -9.52M | -543.00K | 2.29M | 203.00K | 48.00K |
| Deferred Income Tax | n/a | n/a | -2.29M | -203.00K | -48.00K |
| Change in Working Capital | -1.56M | 4.09M | 4.63M | 1.95M | 334.00K |
| Operating Cash Flow | -91.95M | -52.63M | -33.51M | -14.63M | -9.17M |
| Capital Expenditures | -5.75M | -5.55M | -668.00K | -203.00K | -180.00K |
| Acquisitions | n/a | 65.03K | 241.56K | n/a | n/a |
| Purchase of Investments | -255.87M | -292.39M | -288.20M | -24.18M | n/a |
| Sales Maturities Of Investments | 364.50M | 227.36M | 46.64M | n/a | n/a |
| Other Investing Acitivies | n/a | -65.03K | -241.56K | -24.18K | n/a |
| Investing Cash Flow | 102.89M | -70.58M | -242.23M | -24.38M | -180.00K |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 1.26M | 474.00K | 236.00K | 120.28M | 24.80M |
| Financial Cash Flow | 53.17M | 129.64M | 186.38M | 120.28M | 24.80M |
| Net Cash Flow | 64.10M | 6.43M | -89.35M | 81.26M | 15.45M |
| Free Cash Flow | -97.69M | -58.18M | -34.17M | -14.84M | -9.35M |